GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » PEG Ratio

Beta Drugs (NSE:BETA) PEG Ratio : 0.81 (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Beta Drugs's PE Ratio without NRI is 31.40. Beta Drugs's 5-Year EBITDA growth rate is 38.70%. Therefore, Beta Drugs's PEG Ratio for today is 0.81.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Beta Drugs's PEG Ratio or its related term are showing as below:

NSE:BETA' s PEG Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.37   Max: 1.2
Current: 0.82


During the past 12 years, Beta Drugs's highest PEG Ratio was 1.20. The lowest was 0.02. And the median was 0.37.


NSE:BETA's PEG Ratio is ranked better than
75.34% of 373 companies
in the Drug Manufacturers industry
Industry Median: 1.64 vs NSE:BETA: 0.82

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Beta Drugs PEG Ratio Historical Data

The historical data trend for Beta Drugs's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs PEG Ratio Chart

Beta Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.22 0.58 0.48 0.84

Beta Drugs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 - 0.48 - 0.84

Competitive Comparison of Beta Drugs's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beta Drugs's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Beta Drugs's PEG Ratio falls into.



Beta Drugs PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Beta Drugs's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=31.398416886544/38.70
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Beta Drugs  (NSE:BETA) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Beta Drugs PEG Ratio Related Terms

Thank you for viewing the detailed overview of Beta Drugs's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beta Drugs (NSE:BETA) Business Description

Traded in Other Exchanges
N/A
Address
SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports it to other countries of which key revenue is derived from the sales made in India.

Beta Drugs (NSE:BETA) Headlines

No Headlines